Difference between revisions of "Evaluation of suspected malignancies"
(Started) |
m (Table) |
||
Line 6: | Line 6: | ||
==Focus== | ==Focus== | ||
The primary focus of tumor evaluation is to distinguish benign from malignant types, and in case of malignancy the primary focus is to determine its stage, generally by the TNM classification:<ref>{{cite web |url= http://www.cancer.gov/cancertopics/factsheet/detection/staging |title=Cancer staging |date= |publisher=National Cancer Institute |accessdate=4 January 2013}}</ref> | The primary focus of tumor evaluation is to distinguish benign from malignant types, and in case of malignancy the primary focus is to determine its stage, generally by the TNM classification:<ref>{{cite web |url= http://www.cancer.gov/cancertopics/factsheet/detection/staging |title=Cancer staging |date= |publisher=National Cancer Institute |accessdate=4 January 2013}}</ref> | ||
+ | {|class="wikitable" | ||
+ | | | ||
'''T''': size or direct extent of the primary tumor | '''T''': size or direct extent of the primary tumor | ||
** Tx: tumor cannot be assessed | ** Tx: tumor cannot be assessed | ||
Line 20: | Line 22: | ||
** M0: no distant metastasis | ** M0: no distant metastasis | ||
** M1: metastasis to distant organs (beyond regional lymph nodes) | ** M1: metastasis to distant organs (beyond regional lymph nodes) | ||
− | + | |} | |
Beyond the above mentioned, specific histopathologies of tumors is generally of relatively little value. Thus, in cases where it is difficult to determine whether it is one type of non-malignant histopathologic type or another non-malignant type, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise. | Beyond the above mentioned, specific histopathologies of tumors is generally of relatively little value. Thus, in cases where it is difficult to determine whether it is one type of non-malignant histopathologic type or another non-malignant type, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise. | ||
{{Bottom}} | {{Bottom}} |
Revision as of 03:21, 2 October 2019
Author:
Mikael Häggström [note 1]
Further reading: |
Contents
Focus
The primary focus of tumor evaluation is to distinguish benign from malignant types, and in case of malignancy the primary focus is to determine its stage, generally by the TNM classification:[1]
T: size or direct extent of the primary tumor
N: degree of spread to regional lymph nodes
M: presence of distant metastasis
|
Beyond the above mentioned, specific histopathologies of tumors is generally of relatively little value. Thus, in cases where it is difficult to determine whether it is one type of non-malignant histopathologic type or another non-malignant type, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise.
Notes
- ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.
Main page
References
- ↑ . Cancer staging. National Cancer Institute. Retrieved on 4 January 2013.
Image sources